(Q40851559)

24 September 2017

title

Preliminary report on the treatment of endometriosis with low-dose mifepristone (RU 486). (English)

1 reference

24 September 2017

1 reference

1 reference

L M Kettel

1

1 reference

24 September 2017

A A Murphy

series ordinal

2

1 reference

24 September 2017

A J Morales

series ordinal

3

1 reference

24 September 2017

S S Yen

series ordinal

4

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 June 1998

1 reference

American Journal of Obstetrics and Gynecology

24 September 2017

published in

1 reference

24 September 2017

volume

178

1 reference

24 September 2017

issue

6

1 reference

24 September 2017

page(s)

1151-1156

1 reference

Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970316-3

Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970316-3

Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970316-3

Revised American Fertility Society classification of endometriosis: 1985

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970316-3

Treatment of endometriosis with danazol: report of a 6-year prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970316-3

The effects of RU 486 and leuprolide acetate on uterine artery blood flow in the fibroid uterus: a prospective, randomized study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970316-3

Endometrial effects of long-term low-dose administration of RU486

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970316-3

Therapeutic efficacy and bone mineral density response during and following a three-month re-treatment of endometriosis with nafarelin (Synarel).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970316-3

Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970316-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9378(98)70316-3

1 reference

24 September 2017

1 reference